Pipoxizine
Pipoxizine is a tricyclic antidepressant (TCA) that was developed in the 1960s. It is a member of the dibenzazepine group of TCAs and is structurally related to imipramine and desipramine. Pipoxizine was never marketed.
Pharmacology[edit | edit source]
Pipoxizine acts as a norepinephrine reuptake inhibitor and antihistamine. It is known to have antidepressant, anxiolytic, and antiemetic effects.
History[edit | edit source]
Pipoxizine was developed in the 1960s but was never marketed. The reasons for this are not clear, but it may be due to the drug's side effects or lack of efficacy compared to other TCAs.
Side Effects[edit | edit source]
Like other TCAs, pipoxizine can cause a variety of side effects. These may include dry mouth, constipation, blurred vision, urinary retention, and orthostatic hypotension. In rare cases, it can cause more serious side effects such as cardiac arrhythmias or seizures.
See Also[edit | edit source]
References[edit | edit source]
Pipoxizine Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD